Murphy & Mullick Capital Management Corp Novartis Ag Transaction History
Murphy & Mullick Capital Management Corp
- $109 Billion
- Q4 2024
A detailed history of Murphy & Mullick Capital Management Corp transactions in Novartis Ag stock. As of the latest transaction made, Murphy & Mullick Capital Management Corp holds 650 shares of NVS stock, worth $70,037. This represents 0.06% of its overall portfolio holdings.
Number of Shares
650Holding current value
$70,037% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,444Shares Held
132MCall Options Held
1.12MPut Options Held
1.61M-
Dodge & Cox San Francisco, CA12.2MShares$1.32 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.19 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$872 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$753 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.58MShares$601 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $232B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...